Table 4.
Q1 | Q2 | Q3 | Q4 | P for tread | |
---|---|---|---|---|---|
LVH | 1 | 1.02(0.78–1.34) | 1.10(0.82–1.47) | 1.19(0.85–1.65) | 0.25 |
AS | 1 | 1.31(1.02–1.70) | 1.39(1.05–1.85) | 1.88(1.37–2.58) | <0.001 |
LEA | 1 | 0.64(0.45–0.90) | 0.79(0.55–1.12) | 0.87(0.58–1.29) | 0.96 |
MAU | 1 | 0.91(0.73–1.13) | 1.06(0.84–1.36) | 1.33(1.01–1.75) | 0.02 |
CKD | 1 | 1.35(0.83–2.19) | 1.78(1.08–2.92) | 2.39(1.39–4.12) | <0.001 |
Note: Adjusted for age, sex, hypertension, use of antihypertensive, diabetes, BMI, smoking habit, HDL-C, LDL-C, family history of premature CVD.
Abbreviations: TOD, target organ damage; LAP, lipid accumulation product; LVH, left ventricular hypertrophy; AS, arterial stiffness; LEA, lower extremity atherosclerotic; MAU, micro-albuminuria; CKD, chronic kidney disease; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease.